<?xml version="1.0" encoding="UTF-8"?>
<p>The conduct of clinical trials is commonly characterized by complex heterogeneous, expensive, and time-consuming approval processes,
 <xref rid="bib65 bib66" ref-type="bibr">
  <sup>65,66</sup>
 </xref> and monitoring usually concentrates on retrospective data verification. However, in the current context a risk-based approach to monitoring of clinical trials with emphasis on centralized monitoring is being encouraged.
</p>
